Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs metoprolol vs magnesium sulfate for postoperative bleeding control after craniotomy
IRCT20251002067466N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine, metoprolol and magnesium sulfate in Epidural hematoma (EDH) and subdural hematoma (SDH) (3 arms), sponsored by Arak University of Medical Sciences. Primary endpoint: postoperative bleeding volume. Started Nov 2025; status: completed.
02
Drugs
dexmedetomidinemetoprololmagnesium sulfate
03
Conditions
Epidural hematoma (EDH)subdural hematoma (SDH)
Beyond the preview
Go deeper on IRCT20251002067466N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251002067466N1.